VIRI - Virios Therapeutics Inc. (VIRI) CEO Greg Duncan on Q1 2022 Results - Earnings Call Transcript

Virios Therapeutics, Inc. (VIRI) Q1 2022 Earnings Conference Call May 12, 2022 8:30 a.m. ET Company Participants Angela Walsh - Senior Vice President of Finance, and Treasurer Greg Duncan - Chief Executive Officer Ralph Grosswald - Senior Vice President of Operations Conference Call Participants David Bautz - Zacks Research Presentation Operator Good morning, and welcome to the Virios Therapeutics, Incorporated First Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please be advised that today's call is being recorded at the company's request. At this time, I'd like to turn the call over to Angela Walsh, Senior Vice President of Finance and Treasurer for Virios Therapeutics. Please proceed, Angela. Angela Walsh Thank you. Good morning, everyone, and thank you for joining us on today's conference call. We are pleased to be with you today to discuss Virios Therapeutics first quarter 2022 financial results, as well as to provide you with an

For further details see:

Virios Therapeutics, Inc. (VIRI) CEO Greg Duncan on Q1 2022 Results - Earnings Call Transcript